Diabetes Mellitus, Type 2 Clinical Trial
— MATCHOfficial title:
MATCH: The Mexican-American Trial of Community Health Workers
The MATCH study (Mexican-American Trial of Community Health Workers) tests the hypothesis
that the use of indigenous Community Health Workers (CHWs), recruited from the target
community and trained to provide culturally appropriate diabetes education, can promote
pro-active self-management among inner-city dwelling Mexican-Americans with Type 2 diabetes
mellitus. The study aims are to demonstrate that a CHW, compared to an attention control,
will: 1) result in improvement in short term physiologic outcomes (Hemoglobin A1c levels and
blood pressure), and 2) result in increased frequency of self-management behaviors (daily
self blood-glucose monitoring, medication adherence, adherence to diet and physical activity
recommendations). The study design is a single site, partially blinded, randomized
controlled trial of 144 patients with Type 2 diabetes mellitus.
Eligibility criteria include a diagnosis of Type 2 diabetes, residence in target community
areas in the Chicago area, and Mexican or Mexican-American ethnic heritage. Participants are
randomized to either an experimental group receiving 36 home visits over a two year period
in which a CHW delivered diabetes education and self-management skills training, or to an
attention control consisting of 36 bilingual diabetes education newsletters covering the
same curriculum as the CHWs. The curriculum covers recommended diabetes self-management
behaviors including glucose self-monitoring, responding to abnormal blood glucose levels,
working effectively with health care providers, medication adherence, foot care, daily
physical activity, and reducing fat content of diet. CHWs also deliver training in
behavioral skills of self-monitoring, environmental restructuring, engagement of social
support, stress management, and problem-solving skills to facilitate the self-management
activities. Consistent delivery of the CHW intervention is documented by audiotapes and
Documentation of Intervention worksheets.
| Status | Completed |
| Enrollment | 144 |
| Est. completion date | December 2010 |
| Est. primary completion date | December 2010 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 21 Years and older |
| Eligibility |
Inclusion Criteria: - Diagnosis of type 2 diabetes mellitus - Taking at one oral medication daily to control diabetes - Self-identified as Mexican or Mexican-American - Resident in target community within Chicago, Berwyn, or Cicero, Illinois. Exclusion Criteria: - Diabetes controlled with diet or insulin only - Advanced end-organ complications, including: end-stage renal disease, stroke with paresis, Congestive Heart Failure (NYHA class 3 or 4), or other major end-organ complication of diabetes - Receiving treatment for a major psychiatric disorder (i.e. schizophrenia) - Are unable to understand and give informed consent in either English or Spanish - Live in a household with someone who is already a randomized study participant or know of family members who are already study participants. - Have lived in Mexico for more than four months in the past two years, or are anticipating extended travel to Mexico in the next year. - Are under the age of 18 |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| United States | Rush University Medical Center | Chicago | Illinois |
| Lead Sponsor | Collaborator |
|---|---|
| Rush University Medical Center | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
Martin MA, Swider SM, Olinger T, Avery E, Lynas CM, Carlson K, Rothschild SK. Recruitment of Mexican American adults for an intensive diabetes intervention trial. Ethn Dis. 2011 Winter;21(1):7-12. — View Citation
Swider SM, Martin M, Lynas C, Rothschild S. Project MATCH: training for a promotora intervention. Diabetes Educ. 2010 Jan-Feb;36(1):98-108. doi: 10.1177/0145721709352381. Epub 2009 Dec 11. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Hemoglobin A1c | 2 years | No | |
| Primary | % of persons with blood pressure less than 130/80 | 2 years | No | |
| Secondary | Medication adherence | 2 years | No | |
| Secondary | Daily self-blood glucose monitoring | 2 years | No | |
| Secondary | Summary of Diabetes Self-Care Activities | 2 years | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |